Rhythm Pharmaceuticals buy Guggenheim
Start price
10.07.25
/
50%
€75.50
Target price
10.07.26
-
Performance (%)
10.60%
Price
15.08.25
€84.50
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 10.60%. This prediction currently runs until 10.07.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 9.740% | 9.740% |
| iShares Core DAX® | 0.648% | -0.148% |
| iShares Nasdaq 100 | -0.034% | 1.859% |
| iShares Nikkei 225® | 2.445% | 8.129% |
| iShares S&P 500 | 0.492% | 1.525% |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
06.08.25
06.08.25
€103.73
06.08.26
06.08.26
7.74%
15.08.25
15.08.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.40
21.10.24
21.10.24
€64.45
21.10.25
21.10.25
75.65%
15.08.25
15.08.25